Literature DB >> 30361949

Pharmacology of natural radioprotectors.

Gil-Im Mun1, Seoyoung Kim1, Eun Choi1, Cha Soon Kim2, Yun-Sil Lee3.   

Abstract

Radiotherapy is one of the most efficient ways to treat cancer. However, deleterious effects, such as acute and chronic toxicities that reduce the quality of life, may result. Naturally occurring compounds have been shown to be non-toxic over wide dose ranges and are inexpensive and effective. Additionally, pharmacological strategies have been developed that use radioprotectors to inhibit radiation-induced toxicities. Currently available radioprotectors have several limitations, including toxicity. In this review, we present the mechanisms of proven radioprotectors, ranging from free radical scavenging (the best-known mechanism of radioprotection) to molecular-based radioprotection (e.g., upregulating expression of heat shock proteins). Finally, we discuss naturally occurring compounds with radioprotective properties in the context of these mechanisms.

Entities:  

Keywords:  Mechanisms; Natural compounds; Radioprotectors; Toxicity

Mesh:

Substances:

Year:  2018        PMID: 30361949      PMCID: PMC6224001          DOI: 10.1007/s12272-018-1083-6

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  13 in total

Review 1.  Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry.

Authors:  Elena Obrador; Rosario Salvador-Palmer; Juan I Villaescusa; Eduardo Gallego; Blanca Pellicer; José M Estrela; Alegría Montoro
Journal:  Antioxidants (Basel)       Date:  2022-05-31

2.  Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer.

Authors:  Diala F Hamade; Alexis Espinal; Jian Yu; Brian J Leibowitz; Renee Fisher; Wen Hou; Donna Shields; Jan-Peter van Pijkeren; Amitava Mukherjee; Michael W Epperly; Anda M Vlad; Lan Coffman; Hong Wang; M Saiful Huq; Ravi Patel; Jason Huang; Joel S Greenberger
Journal:  Radiat Res       Date:  2022-07-01       Impact factor: 3.372

3.  Attenuation of Radiation-Induced Lung Injury by Hyaluronic Acid Nanoparticles.

Authors:  Anna Lierova; Jitka Kasparova; Jaroslav Pejchal; Klara Kubelkova; Marcela Jelicova; Jiri Palarcik; Lucie Korecka; Zuzana Bilkova; Zuzana Sinkorova
Journal:  Front Pharmacol       Date:  2020-08-12       Impact factor: 5.810

4.  Fucoxanthin alters the apelin-13/APJ pathway in certain organs of γ-irradiated mice.

Authors:  Nermeen M El Bakary; Noura Magdy Thabet; Neama M El Fatih; Mohamed Khairy Abdel-Rafei; Ghada El Tawill; Khaled Shaaban Azab
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

5.  Protection of wear resistance behaviour of enamel against electron beam irradiation.

Authors:  Mithra N Hegde; Priya Gatti; Nidarsh D Hegde
Journal:  BDJ Open       Date:  2019-07-11

6.  Momordica. charantia-Derived Extracellular Vesicles-Like Nanovesicles Protect Cardiomyocytes Against Radiation Injury via Attenuating DNA Damage and Mitochondria Dysfunction.

Authors:  Wen-Wen Cui; Cong Ye; Kai-Xuan Wang; Xu Yang; Pei-Yan Zhu; Kan Hu; Ting Lan; Lin-Yan Huang; Wan Wang; Bing Gu; Chen Yan; Ping Ma; Su-Hua Qi; Lan Luo
Journal:  Front Cardiovasc Med       Date:  2022-04-18

7.  Quality evaluation of Panax quinquefolium from different cultivation regions based on their ginsenoside content and radioprotective effects on irradiated mice.

Authors:  Dengqun Liao; Chan Jia; Peng Sun; Jianjun Qi; Xian'en Li
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

Review 8.  Oxidative Stress in Radiation-Induced Cardiotoxicity.

Authors:  Zhang Ping; Yang Peng; Hong Lang; Cai Xinyong; Zeng Zhiyi; Wu Xiaocheng; Zeng Hong; Shao Liang
Journal:  Oxid Med Cell Longev       Date:  2020-03-01       Impact factor: 6.543

9.  Radioprotective Effect of Thymoquinone in X-irradiated Rats.

Authors:  Sanaa A El-Benhawy; Mohamed I Morsi; Rasha A El-Tahan; Noura A Matar; Hawa Mg Ehmaida
Journal:  Asian Pac J Cancer Prev       Date:  2021-09-01

10.  Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study.

Authors:  Wanqi Zhu; Yalan Zhao; Shuyu Zhang; Xiaolin Li; Ligang Xing; Hanxi Zhao; Jinming Yu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.